Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma

BackgroundPancreatic cancer is one of the principal causes of tumor-related death worldwide. CXC chemokines, a subfamily of functional chemotactic peptides, affect the initiation of tumor cells and clinical outcomes in several human malignant tumors. However, the specific biological functions and cl...

Full description

Bibliographic Details
Main Authors: Jiacheng Huang, Zhitao Chen, Chenchen Ding, Shengzhang Lin, Dalong Wan, Kuiwu Ren
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
CXC chemokines
prognostic biomarkers
immunotherapeutic targets
bioinformatics
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.711402/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.711402/full

Similar Items